Days after Los Angeles reintroduced an indoor mask mandate, the nation’s second-largest city was revisiting debates many hoped were left in 2020.
Posts published in “Business”
Kimberly-Clark Corp.’s shares fell after the maker of household supplies missed Wall Street’s expectations for second-quarter earnings and trimmed its annual forecast, saying inflationary pressures and slowing toilet paper demand are hurting results.
Long hours during the pandemic and lengthy stints of working remotely have left some finance employees feeling miserable, but some junior staffers at Blackstone Group Inc. have a different story to tell.
Topline American tennis star Serena Williams retired from her first round match at Wimbledon on Tuesday after suffering an injury, ending her quest of tying the record for most-ever Grand Slam tournament wins by a woman through winning this year’s tournament. Key Facts This is only the second time Williams, 39, has retired from a…
The FBI is using a controversial technology traditionally used to locate smartphones as a car tracking surveillance tool that spies on vehicles’ on-board WiFi. Known as a Stingray or a cell-site simulator, the tool masquerades as a cell tower in order to force all devices in a given area to connect into it. Agents can…
What’s happening? Tough talk on Northern Ireland, and a Brexit-exacerbated trucker shortage adds to “pingdemic” woes.
Biogen Inc. fought back against criticism of the unusual circumstances that led to the U.S. approval of its Alzheimer’s drug Aduhelm, saying in an open letter it has been the subject of “extensive misinformation and misunderstanding.”
Fort Worth, Texas (AP) -- American Airlines eked out a second-quarter profit of $19 million, its first since the pandemic started, thanks to nearly $1.5 billion in federal relief.
Chinese regulators are considering serious, perhaps unprecedented, penalties for Didi Global Inc. after its controversial initial public offering last month, according to people familiar with the matter.
Abbott Laboratories posted stronger-than-expected second-quarter profit and revenue results, even as demand for its Covid-19 testing products dropped when U.S. virus cases ebbed in the spring.